| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Familial partial lipodystrophy fpld 0.8362065561051295 2.4995956876317544 0.0124335116342597 0.9994367853721506 0.8779195075033205 8 O75844,O60725 2 |
| Vitamin a and carotenoid metabolism 0.931780861900816 2.4436314547501845 0.014540271411189 0.9998429452776336 0.8779195075033205 5 Q8WTV0 1 |
| Oxidation by cytochrome p450 0.8501847496192222 2.297654753910965 0.0215814466639059 0.9999978434560662 0.8779195075033205 6 Q16850,O43169 2 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.883712437045925 2.252608014613902 0.0242838753375145 0.9999995874825262 0.8779195075033205 5 O60725 1 |
| Pparalpha pathway 0.8489871744685024 2.1902328110169256 0.0285073567998963 0.9999999691801392 0.8779195075033205 7 P23786 1 |
| Sphingolipid metabolism integrated pathway 0.7611631417646395 2.14316353721046 0.0320999690287799 0.9999999966376628 0.8779195075033205 9 O95470,Q8N5B7,Q16880,Q06136,O15269,Q16739,Q96G23 7 |
| Sphingolipid metabolism overview 0.7520546117621243 2.1207334565308447 0.0339442393520903 0.9999999989252378 0.8779195075033205 8 O95470,Q16880,Q06136,O15269,Q16739,Q96G23 6 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8477716871152405 2.1070790744407546 0.0351107258589302 0.999999999478166 0.8779195075033205 5 Q15392,Q16850,Q9UBM7 3 |
| Mitochondrial complex iii assembly 0.7407163560758129 2.029482460751403 0.0424091736546909 0.9999999999944328 0.8779195075033205 10 O14949,P22695,P08574,Q9UDW1,Q9BRT2 5 |
| Metabolism of spingolipids in er and golgi apparatus 0.8040888553175783 1.9271708970498345 0.0539583356059367 0.999999999999996 0.8779195075033205 5 Q16739,O95470,Q06136 3 |
| Mitochondrial long chain fatty acid betaoxidation 0.7298536356014336 1.921355287428369 0.0546869314113989 0.9999999999999976 0.8779195075033205 13 P11310,P23786 2 |
| Sphingolipid pathway 0.7256427946953214 1.9207803096799123 0.0547594098618708 0.9999999999999976 0.8779195075033205 12 O95470,Q8N5B7,Q16880,Q06136,O15269,Q16739,P04062,Q96G23 8 |
| Kennedy pathway from sphingolipids 0.7918778773147265 1.876307989743136 0.0606130005689351 1.0 0.8779195075033205 5 O95470,P35790 2 |
| Ketogenesis and ketolysis 0.7865624013651615 1.8540921677403328 0.0637259750521332 1.0 0.8779195075033205 5 O43772,P23786,P35610 3 |
| Mitochondrial complex iv assembly 0.6854383495842042 1.7500330158795006 0.0801126168490893 1.0 0.9212950937645272 11 Q9Y2R0,P13073,Q7KZN9,Q8N8Q8,P14406 5 |
| Sphingolipid metabolism in senescence 0.6895069316255111 1.731121258360914 0.0834301395392236 1.0 0.9413438385746364 13 Q06136,O15269,Q16739,P16278,Q96G23 5 |
| Vitamin d metabolism 0.8952440161641269 1.719257918841858 0.0855674187222788 1.0 0.943977020452641 3 P38435,Q9UBM7 2 |
| Progeriaassociated lipodystrophy 0.6693507901947248 1.6922743077126616 0.0905936841505925 1.0 0.943977020452641 10 O75844,O60725 2 |
| Triacylglyceride synthesis 0.7469661226891021 1.6872447512465347 0.0915562996425638 1.0 0.943977020452641 5 Q9NUQ2,Q9HCL2 2 |
| Disruption of postsynaptic signaling by cnv 0.6515646662202028 1.6452456160907478 0.099919169961252 1.0 0.9518806313240608 8 Q14168 1 |
| Adipogenesis 0.6511000304014363 1.546724222936504 0.1219297595017467 1.0 0.9518806313240608 13 P43490,O75844 2 |
| Serotonin htr1 group and fos pathway 0.7121135749009313 1.538615938361497 0.123898085165186 1.0 0.9518806313240608 5 P04899,P63096 2 |
| Statin inhibition of cholesterol production 0.6947595731863286 1.5317267942065775 0.12558986753552 1.0 0.9518806313240608 7 Q8WTV0,P35610 2 |
| Omega3 omega6 fatty acid synthesis 0.6582248688393731 1.4587799099219678 0.1446256937972019 1.0 0.9518806313240608 6 Q15067 1 |
| Fatty acid transporters 0.6929551352759803 1.4563397796852566 0.1452987139462207 1.0 0.9518806313240608 5 Q9UKU0 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6318252979376848 1.4154821624040177 0.1569271747380849 1.0 0.9535085852217896 15 P02545,O75844,P50402,O60725 4 |
| Ppar signaling pathway 0.6354136380392387 1.4142751696053597 0.157281124555078 1.0 0.9535085852217896 16 P33121,Q9UKU0,P23786,P11310,Q15067 5 |
| Copper homeostasis 0.667572475040638 1.4113912865722722 0.1581292707899773 1.0 0.9535085852217896 7 P49841,P05067,P35670 3 |
| Influence of laminopathies on wnt signaling 0.600958641413129 1.3396540801778876 0.18035783302717 1.0 0.9535085852217896 11 P02545,O75844,O60725 3 |
| Riboflavin and coq disorders 0.6317525797814377 1.3382914315633516 0.1808014538893769 1.0 0.9535085852217896 6 O75208,Q86YH6,Q16134 3 |
| 1q211 copy number variation syndrome 0.5992751387956421 1.3313491597242946 0.1830741496386296 1.0 0.9535085852217896 11 Q9NPH0,Q13131 2 |
| Striated muscle contraction pathway 0.7033596300588166 1.330459154213638 0.1833670356195749 1.0 0.9535085852217896 4 P08670 1 |
| Tryptophan metabolism 0.6095636913338334 1.3068066962598663 0.1912783703872791 1.0 0.9685712786510472 15 Q15392,O94788 2 |
| Vitamin d in inflammatory diseases 0.6958737183942271 1.2998653387379064 0.1936471266328943 1.0 0.9685712786510472 4 O14920 1 |
| Endothelin pathways 0.6400053216597771 1.288457042547079 0.1975869131566172 1.0 0.9685712786510472 7 P16615,P42892 2 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.5785373772598678 1.2666850645655896 0.2052679225028195 1.0 0.978315367338506 9 Q9NR77,Q8TB36,O95140 3 |
| Purinergic signaling 0.774013055641889 1.2623880649377983 0.2068091817335624 1.0 0.978315367338506 3 P04899,P63096 2 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.6317529295205028 1.2513050082235868 0.2108232189654404 1.0 0.9817211326840616 24 P33121,Q15392,P04035,Q9UBM7,P35610,Q15800,P56937,Q16850,Q14739 9 |
| Cytosine methylation 0.625119443349745 1.163261242265597 0.2447235255988133 1.0 1.0 5 P48735 1 |
| Type ii diabetes mellitus 0.6569932832322465 1.1411651294457013 0.253801212385768 1.0 1.0 4 O14920 1 |
| Fatty acid betaoxidation 0.5931078374153554 1.1353046207753166 0.2562477068243445 1.0 1.0 20 O43772,P11310,P23786 3 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.6141843903448015 1.1160107318333337 0.2644175408912641 1.0 1.0 5 P42345,Q13131 2 |
| Sarscov2 and covid19 pathway 0.6472653086740835 1.101601526524898 0.2706349443927287 1.0 1.0 4 Q8WTV0 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.5476356935064455 1.0567993218728635 0.2906031838784801 1.0 1.0 12 Q32P28,O15460 2 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.5964673084316667 1.0396427127374082 0.2985059250239494 1.0 1.0 5 P09601 1 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.6157140333977595 0.9741130338015253 0.3300004186489917 1.0 1.0 4 P06730 1 |
| Metapathway biotransformation phase i and ii 0.5588688889375354 0.9512341687835446 0.341485516746046 1.0 1.0 21 Q9H0A0,P78417,Q6UW02,P34913,P07099,Q16850,Q8NCH0,Q7LGA3 8 |
| Cholesterol biosynthesis pathway 0.5276028863337915 0.9394584839489484 0.3474953980158917 1.0 1.0 13 Q15800,P04035,Q9UBM7,Q16850 4 |
| Common pathways underlying drug addiction 0.5443100171945028 0.9382144183566532 0.3481342301363266 1.0 1.0 6 P63096 1 |
| Neuroinflammation 0.6779137903446576 0.9047928396261444 0.3655751457610399 1.0 1.0 3 P42345 1 |
| Immune response to tuberculosis 0.6711221635063752 0.8801733100268895 0.3787654298285356 1.0 1.0 3 Q03518,O60244 2 |
| Arachidonate epoxygenase epoxide hydrolase 0.8505282784338108 0.8749851334606058 0.3815819947903347 1.0 1.0 2 P34913 1 |
| Mitochondrial complex i assembly model oxphos system 0.5533450761916282 0.8399347372737213 0.4009449795266726 1.0 1.0 26 P03886,O95168,O75306,O43676,Q9Y6M9,Q9P0J0,Q96CU9 7 |
| Ferroptosis 0.5242213867683185 0.7842438739124371 0.4328970256616555 1.0 1.0 21 P04035,Q9UKU0,P45880,Q15043,P09601,Q9Y277 6 |
| Melatonin metabolism and effects 0.8182100683654272 0.765428242849039 0.4440165805230143 1.0 1.0 2 P42892 1 |
| Ebsteinbarr virus lmp1 signaling 0.6348530639539465 0.7512233467457076 0.4525182518453365 1.0 1.0 3 O14920 1 |
| Estrogen receptor pathway 0.6313797637704897 0.7391365511914912 0.459824083911861 1.0 1.0 3 Q9HCL2 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.5554271694683037 0.7371625366790174 0.4610235127696453 1.0 1.0 4 P49841 1 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.5488184079601923 0.7120136166284773 0.4764563441093714 1.0 1.0 4 Q16539,P42224,P09543 3 |
| Interactions between loxl4 and oxidative stress pathway 0.6183203325740434 0.6941755024946297 0.4875721536167272 1.0 1.0 3 Q9BQ95 1 |
| Proteoglycan biosynthesis 0.5117679650575528 0.6835929292447486 0.4942322508181487 1.0 1.0 5 Q8TB61,Q8NCH0 2 |
| Signal transduction through il1r 0.5267598130544215 0.6297189930082441 0.5288784538116271 1.0 1.0 4 Q9BQ95 1 |
| Insulin signaling in adipocytes normal condition 0.5254695561204024 0.6249923588026034 0.5319760731948535 1.0 1.0 4 P42345 1 |
| Insulin signaling in adipocytes diabetic condition 0.5254695561204024 0.6249923588026034 0.5319760731948535 1.0 1.0 4 P42345 1 |
| 7oxoc and 7betahc pathways 0.4434792830672244 0.598683895882526 0.5493836981947862 1.0 1.0 9 O15118,Q9UBM7 2 |
| Nuclear receptors in lipid metabolism and toxicity 0.7660037290242427 0.5981011134711661 0.5497724673506303 1.0 1.0 2 P28288 1 |
| Allograft rejection 0.4382369382950403 0.5737766346849241 0.5661189619513856 1.0 1.0 9 P01889,P08670,P10321,P04439 4 |
| Nephrotic syndrome 0.4543421954222202 0.5682546458832257 0.5698620705636641 1.0 1.0 14 P02545,Q9BT22,O75844 3 |
| Oxysterols derived from cholesterol 0.476151547915713 0.5636814543751343 0.5729709410109347 1.0 1.0 7 Q9UBM7 1 |
| Hepatitis c and hepatocellular carcinoma 0.4344124313226003 0.5557139981971859 0.5784063856400472 1.0 1.0 9 P31350 1 |
| Spinal cord injury 0.4613481345450819 0.5531074494404948 0.5801898359363451 1.0 1.0 17 Q9NQC3 1 |
| Celltype dependent selectivity of cck2r signaling 0.7256059664387717 0.4795601345226419 0.6315401990141445 1.0 1.0 2 P63096 1 |
| Sting pathway in kawasakilike disease and covid19 0.723741454319459 0.4743664340669084 0.6352386246755779 1.0 1.0 2 O14920 1 |
| G protein signaling pathways 0.4354857639853218 0.4511723458883314 0.6518653391039289 1.0 1.0 16 O43823,P04899,O43572,P05771,Q9UBI6,P63096,P08754 7 |
| Myometrial relaxation and contraction pathways 0.445204460698003 0.4350118564886372 0.6635538213587233 1.0 1.0 20 P78417,P05771,P16615,P10644,Q9UBI6,P50148,Q04917 7 |
| Hedgehog signaling pathway wp47 0.7060285891858364 0.4263802815806422 0.6698307673031745 1.0 1.0 2 Q96ST3 1 |
| Atm signaling pathway 0.4197860274524554 0.4262449847684325 0.6699293413874525 1.0 1.0 13 Q9BXW9,P38398,P14635 3 |
| Cohesin complex cornelia de lange syndrome 0.4330811207229443 0.4257303712755653 0.6703043286305634 1.0 1.0 17 Q9NTI5,Q29RF7,Q7Z5K2,Q9Y6X3,Q16537 5 |
| Cellular proteostasis 0.4675017424444587 0.4254604816108295 0.6705010239909219 1.0 1.0 4 Q9UHV9,Q99471 2 |
| Omega9 fatty acid synthesis 0.4253877922948657 0.4237633205563953 0.6717384306713214 1.0 1.0 6 P33121 1 |
| Gpr143 in melanocytes and retinal pigment epithelium cells 0.5298778890046503 0.4170230205299569 0.6766615695878624 1.0 1.0 3 P05771 1 |
| Reninangiotensinaldosterone system raas 0.702299564947179 0.4166018141787768 0.6769696821582709 1.0 1.0 2 P50148 1 |
| Airway smooth muscle cell contraction 0.437947122861583 0.4033952743249752 0.6866574626573749 1.0 1.0 5 P62140,Q13464,P50148,P31150 4 |
| Ethanol effects on histone modifications 0.3991094311944139 0.3651327050665088 0.7150123486908821 1.0 1.0 11 O94788 1 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.4252495240179603 0.3594656687141019 0.7192467562484925 1.0 1.0 7 O14920,P05771,Q13555 3 |
| Oxidative phosphorylation 0.4617230642732665 0.352375640960677 0.7245565676492858 1.0 1.0 31 O75787,P03886,Q86Y39,O75964,O95168,P24539,O75306,Q9Y6M9 8 |
| Resistin as a regulator of inflammation 0.4195956454121347 0.3415978861226794 0.7326535282419999 1.0 1.0 5 O14920,Q16539,P28482,P31751 4 |
| T cell receptor and costimulatory signaling 0.4195956454121184 0.3415978861226266 0.7326535282420397 1.0 1.0 5 Q08209,P49841,Q15118,P48729 4 |
| Folate metabolism 0.405437941926511 0.3355972835080451 0.7371745727672194 1.0 1.0 15 Q8WTV0 1 |
| 3q29 copy number variation syndrome 0.3937076766384768 0.3280146945461196 0.742900552122997 1.0 1.0 12 Q13177,Q09161,Q8NCM8,O95684,Q12959 5 |
| Hematopoietic stem cell gene regulation by gabp alphabeta complex 0.4954926950575166 0.3268583895213932 0.7437749942638607 1.0 1.0 3 P51532,Q07820 2 |
| Microglia pathogen phagocytosis pathway 0.4222636815920311 0.2926751250439212 0.76977048506339 1.0 1.0 4 P07948,P63000,O00443 3 |
| Kisspeptinkisspeptin receptor system in the ovary 0.4219527363183991 0.2918485033235161 0.7704024584704572 1.0 1.0 4 P05771,P28482,P31751 3 |
| Mitochondrial immune response to sarscov2 0.3750619636388112 0.2917829392152005 0.7704525904368555 1.0 1.0 9 Q9Y6M9 1 |
| Exerciseinduced circadian regulation 0.3908127303909221 0.2757175322821914 0.7827650285938741 1.0 1.0 15 Q12874 1 |
| 15q112 copy number variation syndrome 0.4098258706467618 0.2606158413676265 0.7943887721087357 1.0 1.0 4 Q9BSJ2,Q7L576,Q06787 3 |
| Electron transport chain oxphos system in mitochondria 0.5011097284872451 0.2489936740485307 0.8033656747259952 1.0 1.0 52 P03886,O75964,O95168,O14949,Q7KZN9,Q9UDW1,P24539,O75306,O43676,Q9Y6M9,P14406 11 |
| S1p receptor signal transduction 0.3941894286777359 0.2472111014854171 0.804744854156578 1.0 1.0 7 P04899,P63096 2 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.6267868241143666 0.24607202180351 0.805626480646406 1.0 1.0 2 Q07820 1 |
| Pi3kaktmtor vitd3 signaling 0.3838544743012752 0.233656200205293 0.8152518936878954 1.0 1.0 5 P49841,P42345 2 |
| Dna mismatch repair 0.3890497747578848 0.2308085195574503 0.8174635622771027 1.0 1.0 18 P28340,P41440,P49005,Q9UQ84,P40937 5 |
| Microrna network associated with chronic lymphocytic leukemia 0.6183965195773875 0.230631962125665 0.8176007347345067 1.0 1.0 2 Q07820 1 |
| Nonalcoholic fatty liver disease 0.4942764086425628 0.2241787127576839 0.8226182467183314 1.0 1.0 52 O14949,O75306,O43676,P14406,Q86Y39,O95168,Q9UDW1,Q13131,P49841,P08574,O95139,P13073,O14920,Q9P0J0,P20674,O96000,O14548,Q9Y6M9,P22695 19 |
| Ptf1a related regulatory pathway 0.4327012744793399 0.196222989042351 0.8444356351638151 1.0 1.0 3 P35222,O00330 2 |
| Nitric oxide metabolism in cystic fibrosis 0.4308361827789955 0.1930743730379347 0.8469007223783727 1.0 1.0 3 O14744,O60678 2 |
| Thermogenesis 0.4087398040212496 0.1856782497571734 0.852697085878166 1.0 1.0 28 O43772,P33121,Q8TAQ2,Q9UKU0,P23786,Q13131 6 |
| Pkcgamma calcium signaling pathway in ataxia 0.4218215728940034 0.1784665225062479 0.8583566102820295 1.0 1.0 3 P50148,P23634 2 |
| Autophagy 0.3438007856398499 0.1707374717408717 0.8644301972342847 1.0 1.0 9 Q7Z3C6,P42345,Q13131 3 |
| Cardiac hypertrophic response 0.3356945064766221 0.1420863276572048 0.887011817553816 1.0 1.0 9 O14920,P49841 2 |
| Target of rapamycin tor signaling 0.3320194097001069 0.1187869457821703 0.9054441512094308 1.0 1.0 10 P04035,P42345,Q13131 3 |
| Cannabinoid receptor signaling 0.3346811819595611 0.1171678078673054 0.9067270767713798 1.0 1.0 5 Q16539,P17612,P10644,P28482 4 |
| Prostaglandin and leukotriene metabolism in senescence 0.3690013711382605 0.11275215156605 0.9102270538615936 1.0 1.0 3 P63096 1 |
| Hippo signaling regulation pathways 0.3522256700776809 0.1119745144066225 0.9108436140225412 1.0 1.0 17 P04899,P05771,P10644,Q13043,Q13131,P54646,P08754,P42345 8 |
| Wntbetacatenin signaling pathway in leukemia 0.3306886290539504 0.1090659997911867 0.9131501422104172 1.0 1.0 4 P49841 1 |
| Fas ligand pathway and stress induction of heat shock proteins 0.3288153263690222 0.098016856436446 0.921918908319056 1.0 1.0 11 P02545,Q13813,P78527 3 |
| Dna replication 0.3880515493119802 0.0958884028272625 0.9236092053393472 1.0 1.0 30 P41440,P28340,P49005,Q9Y619,P25205,P40937,P49736 7 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.3409197939060234 0.0905320137664612 0.9278644550903584 1.0 1.0 3 P49841 1 |
| Exrna mechanism of action and biogenesis 0.4975139838409097 0.087942787300418 0.929922148976052 1.0 1.0 2 Q9HAV4 1 |
| Nucleotidebinding oligomerization domain nod pathway 0.3384597633905262 0.0800358144317634 0.9362087715270304 1.0 1.0 7 Q7L5N1,O14920,Q9P0J0,P07900 4 |
| Complement system 0.3210578277385212 0.0739618339867365 0.9410407541140672 1.0 1.0 11 P26885,P08754,P04899 3 |
| Genes related to primary cilium development based on crispr 0.3298309702808706 0.0717773083151859 0.9427791315731356 1.0 1.0 14 A0AVF1,Q10713,Q8NCM8,Q9Y496,O95684 5 |
| Liver x receptor pathway 0.4142324425108893 0.0572842861835594 0.9543187376061356 1.0 1.0 2 O00767 1 |
| Folatealcohol and cancer pathway hypotheses 0.3430702299565072 0.050944265415984 0.959369932581586 1.0 1.0 2 Q99707 1 |
| Tolllike receptor signaling pathway 0.3036437246963589 0.0417981216213376 0.9666596324350618 1.0 1.0 9 P42224,O00459,P63000,P28482,O14920,Q16539,Q13546,P31751 8 |
| Il1 signaling pathway 0.3036437246963587 0.0417981216213368 0.9666596324350624 1.0 1.0 9 O00459,P61088,P28482,P19174,O14920,Q16539,Q06124,Q9BQ95 8 |
| 16p112 distal deletion syndrome 0.2970232345990119 0.0323053608099457 0.9742285341295688 1.0 1.0 8 Q9H2V7 1 |
| Angiogenesis 0.2674961119751122 0.0234736030182248 0.98127249442173 1.0 1.0 5 Q16539,P28482,P19174,Q05397 4 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3641553824243745 0.0111842670161649 0.9910764320625828 1.0 1.0 32 Q9HCL2,Q15437,Q16850,Q13131,Q8WTV0 5 |
| Novel intracellular components of rigilike receptor rlr pathway 0.2963006103886214 0.0059441424057652 0.9952572884761453 1.0 1.0 11 O14920,Q86UT6,Q13526 3 |
|
|
